BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Deb PK. Therapeutic Potentials of Adenosine Receptors: The State of The Art. Curr Pharm Des 2019;25:2789-91. [PMID: 31674891 DOI: 10.2174/138161282526191007143942] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Metzner K, Gross T, Balzulat A, Wack G, Lu R, Schmidtko A. Lack of efficacy of a partial adenosine A1 receptor agonist in neuropathic pain models in mice. Purinergic Signal 2021;17:503-14. [PMID: 34313915 DOI: 10.1007/s11302-021-09806-6] [Reference Citation Analysis]
2 Shaw S, Uniyal A, Gadepalli A, Tiwari V, Belinskaia DA, Shestakova NN, Venugopala KN, Deb PK, Tiwari V. Adenosine receptor signalling: Probing the potential pathways for the ministration of neuropathic pain. European Journal of Pharmacology 2020;889:173619. [DOI: 10.1016/j.ejphar.2020.173619] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Audebrand A, Désaubry L, Nebigil CG. Targeting GPCRs Against Cardiotoxicity Induced by Anticancer Treatments. Front Cardiovasc Med 2019;6:194. [PMID: 32039239 DOI: 10.3389/fcvm.2019.00194] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]